Coherus Oncology (CHRS) Other financing activities (2014 - 2026)
Coherus Oncology's Other financing activities was $3,000 in Q2 2026, down 81.3% from $16,000 a year earlier and down 97.3% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Other financing activities (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Coherus Oncology's Other financing activities was $140,000 through Jun 30, 2026, down 53.3% year-over-year; for FY2025, it came in at -$832,000.
- In earlier years, Other financing activities was $2.48 million in FY2024 (-31.0%), $3.59 million in FY2023 (-4.2%), $3.74 million in FY2022 (+113.6%) and $1.75 million in FY2021 (+99.2%).
- Quarterly Other financing activities has moved between $3,000 (Q3 2025) and $2.78 million (Q1 2023) over five years.
- Compared with a year earlier, Other financing activities was higher in 1 of the last eight quarters, with an average decline of 55.1%.
- The best year-over-year quarter for Other financing activities over five years was Q2 2024 (growth of 461.0%); the worst was Q2 2025 (a decline of 99.1%).
- Per Business Quant data, CHRS's Other financing activities in the three quarters before Q2 2026 was $112,000 (Q1 2026), $22,000 (Q4 2025) and $3,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 115,000.00 |
| Mar 31, 2026 | -112,000.00 |
| Dec 31, 2025 | -261,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Mar 31, 2025 | -264,000.00 |
| Dec 31, 2024 | -2.49 Mn |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -1.71 Mn |
| Mar 31, 2024 | -745,000.00 |
| Dec 31, 2023 | -4.05 Mn |
| Sep 30, 2023 | -115,000.00 |
| Jun 30, 2023 | -305,000.00 |
| Mar 31, 2023 | -2.78 Mn |
| Dec 31, 2022 | -4.23 Mn |
| Sep 30, 2022 | -321,000.00 |
| Jun 30, 2022 | -642,000.00 |
| Mar 31, 2022 | -2.66 Mn |
| Dec 31, 2021 | -1.96 Mn |
| Sep 30, 2021 | -179,000.00 |
API Access
Coherus Oncology Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();